These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2441028)

  • 41. The alpha1L-adrenoceptor subtype in the lower urinary tract: a comparison of human urethra and prostate.
    Fukasawa R; Taniguchi N; Moriyama N; Ukai Y; Yamazaki S; Ueki T; Kameyama S; Kimura K; Kawabe K
    Br J Urol; 1998 Nov; 82(5):733-7. PubMed ID: 9839591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding and functional properties of doxazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    Prostate; 1990; 16(1):29-38. PubMed ID: 1968249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate.
    James S; Chapple CR; Phillips MI; Greengrass PM; Davey MJ; Turner-Warwick RT; Milroy EJ; Burnstock G
    J Urol; 1989 Aug; 142(2 Pt 1):438-44. PubMed ID: 2473223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.
    Foglar R; Shibata K; Horie K; Hirasawa A; Tsujimoto G
    Eur J Pharmacol; 1995 Jan; 288(2):201-7. PubMed ID: 7536677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
    Hatano A; Tang R; Walden PD; Lepor H
    Eur J Pharmacol; 1996 Oct; 313(1-2):135-43. PubMed ID: 8905340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha 1-adrenoceptors in the corneal endothelium.
    Walkenbach RJ; Ye GS; Reinach PS; Boney F
    Exp Eye Res; 1992 Sep; 55(3):443-50. PubMed ID: 1330667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha-1 adrenoceptor subtypes (high, low) in human benign prostatic hypertrophy tissue according to the affinities for prazosin.
    Takeda M; Hatano A; Komeyama T; Koizumi T; Mizusawa T; Kanai T; Tomita Y; Maruyama K; Nagatomo T
    Prostate; 1997 Jun; 31(4):216-22. PubMed ID: 9180931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and regional distribution of alpha 2-adrenoceptors in postmortem human brain using the full agonist [3H]UK 14304.
    Meana JJ; Barturen F; García-Sevilla JA
    J Neurochem; 1989 Apr; 52(4):1210-7. PubMed ID: 2538564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha1-adrenoceptors in testosterone-induced prostatic hypertrophy.
    Auger-Pourmarin L; Roubert P; Chabrier PE
    Eur J Pharmacol; 1998 Jan; 341(1):119-26. PubMed ID: 9489864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation.
    Chapple CR; Aubry ML; James S; Greengrass PM; Burnstock G; Turner-Warwick RT; Milroy EJ; Davey MJ
    Br J Urol; 1989 May; 63(5):487-96. PubMed ID: 2471572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypokalemia modulates alpha- and beta-adrenoceptor bindings in rat skeletal muscle.
    Hirata A; Yoshida H; Oyama Y; Akaike N
    Cell Mol Neurobiol; 1986 Sep; 6(3):255-62. PubMed ID: 3026629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
    Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
    Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate.
    Honda K; Nakagawa C
    J Pharmacol Exp Ther; 1986 Nov; 239(2):512-6. PubMed ID: 2877084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral-type benzodiazepine receptors in human prostate.
    Escubedo E; Camins A; Tresserra F; Adzet T; Camarasa J
    Pharmacology; 1993; 46(2):115-20. PubMed ID: 7680136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha 1-adrenoceptor subtypes in bovine prostate.
    Maruyama K; Tsuchihashi H; Baba S; Mano F; Nagatomo T
    J Pharm Pharmacol; 1992 Sep; 44(9):727-30. PubMed ID: 1360523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The stereospecificity of LY253352 for alpha 1-adrenoceptor binding sites in the brain and prostate.
    Lepor H; Baumann M; Shapiro E
    Br J Pharmacol; 1988 Sep; 95(1):139-44. PubMed ID: 2851347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reconstitution of alpha 1-adrenoceptors having high affinity for prazosin.
    Valliere JE; DeLuca AW; Shreeve SM
    Eur J Pharmacol; 1992 Jul; 226(3):191-7. PubMed ID: 1330629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen receptors in human prostate: evidence for multiple binding sites.
    Ekman P; Barrack ER; Greene GL; Jensen EV; Walsh PC
    J Clin Endocrinol Metab; 1983 Jul; 57(1):166-76. PubMed ID: 6189851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Quantitative analyses of alpha-adrenoceptors in human prostatic capsule, adenoma and urethra--a comparison between normal prostate and hypertrophied prostate].
    Morita T; Kondo S
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):328-33. PubMed ID: 1373455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.